• Aptamer and WuXi AppTec Form Research Partnership contractpharma
    July 23, 2021
    ​Aptamer Group, the developer of Optimer therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, have entered a research collaboration to identify new Optimer-enabled therapeutics.
  • Aptamer Group Collaborates with PinotBio contractpharma
    June 03, 2021
  • Aptamer Extends Collaboration with AstraZeneca contractpharma
    March 08, 2021
  • Aptamer Group, AstraZeneca extend collaboration to explore next-gen drug delivery approaches expresspharma
    March 05, 2021
    The companies will evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.
PharmaSources Customer Service